Rate- and rhythm-control therapies in patients with atrial fibrillation: A systematic review

Annals of Internal Medicine

Volumn 160, Issue 11, 2014, Pages 760-773

  Al Khatib, Sana M ^a   LaPointe, Nancy M Allen ^a   Chatterjee, Ranee ^a,b   Crowley, Matthew J ^a,c   Dupre, Matthew E ^a   Kong, David F ^a   Lopes, Renato D ^a   Povsic, Thomas J ^a,d   Raju, Shveta S ^a,e   Shah, Bimal ^a   Kosinski, Andrzej S ^a   McBroom, Amanda J ^a   Sanders, Gillian D ^a  

^a DUKE CLINICAL RESEARCH INSTITUTE   (United States)

^b Sutton Station Internal Medicine   (United States)

^c DURHAM VA MEDICAL CENTER   (United States)

^d DUKE UNIVERSITY MEDICAL CENTER   (United States)

^e Gwinnett Health System   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIODARONE; BISOPROLOL; FLECAINIDE; PROPAFENONE; SOTALOL; VERAPAMIL;

CARDIAC PATIENT; CARDIOVERSION; CEREBROVASCULAR ACCIDENT; COMPARATIVE EFFECTIVENESS; DUAL CHAMBER PACEMAKER; HEART ATRIUM FIBRILLATION; HEART EJECTION FRACTION; HEART SURGERY; HUMAN; INTERVENTIONAL CARDIOVASCULAR PROCEDURE; MORTALITY; PRIORITY JOURNAL; PULMONARY VEIN ISOLATION; RATE CONTROL THERAPY; RECURRENT DISEASE; REVIEW; RHYTHM CONTROL THERAPY; SINGLE CHAMBER PACEMAKER; SINUS RHYTHM;

ANTI-ARRHYTHMIA AGENTS; ATRIAL FIBRILLATION; CATHETER ABLATION; ELECTRIC COUNTERSHOCK; HEART RATE; HUMANS;

EID: 84901803397     PISSN: 00034819     EISSN: 15393704     Source Type: Journal    
DOI: 10.7326/M13-1467     Document Type: Review

References (182)

1. Go AS, Hylek EM, Phillips KA, Chang Y, Henault LE, Selby JV, et al. Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study. JAMA. 2001;285:2370-5. [PMID: 11343485] (Pubitemid 32424106)
2. Krahn AD, Manfreda J, Tate RB, Mathewson FA, Cuddy TE. The natural history of atrial fibrillation: incidence, risk factors, and prognosis in the Manitoba Follow-Up Study. Am J Med. 1995;98:476-84. [PMID: 7733127]
3. Poole-Wilson PA, Swedberg K, Cleland JG, Di Lenarda A, Hanrath P, Komajda M, et al Carvedilol Or Metoprolol European Trial Investigators. Comparison of carvedilol and metoprolol on clinical outcomes in patients with chronic heart failure in the Carvedilol Or Metoprolol European Trial (COMET): randomised controlled trial. Lancet. 2003;362:7-13. [PMID: 12853193] (Pubitemid 36835815)
4. Maggioni AP, Latini R, Carson PE, Singh SN, Barlera S, Glazer R, et al Val-HeFT Investigators. Valsartan reduces the incidence of atrial fibrillation in patients with heart failure: results from the Valsartan Heart Failure Trial (Val-HeFT). Am Heart J. 2005;149:548-57. [PMID: 15864246] (Pubitemid 40585420)
5. Wang TJ, Larson MG, Levy D, Vasan RS, Leip EP, Wolf PA, et al. Temporal relations of atrial fibrillation and congestive heart failure and their joint influence on mortality: the Framingham Heart Study. Circulation. 2003;107:2920-5. [PMID: 12771006] (Pubitemid 36736633)
6. Wolf PA, Abbott RD, Kannel WB. Atrial fibrillation as an independent risk factor for stroke: the Framingham Study. Stroke. 1991;22:983-8. [PMID: 1866765]
7. Singh SN, Tang XC, Singh BN, Dorian P, Reda DJ, Harris CL, et al SAFE-T Investigators. Quality of life and exercise performance in patients in sinus rhythm versus persistent atrial fibrillation: a Veterans Affairs Cooperative Studies Program Substudy. J Am Coll Cardiol. 2006;48:721-30. [PMID: 16904540] (Pubitemid 44175705)
8. Dorian P, Jung W, Newman D, Paquette M, Wood K, Ayers GM, et al. The impairment of health-related quality of life in patients with intermittent atrial fibrillation: implications for the assessment of investigational therapy. J Am Coll Cardiol. 2000;36:1303-9. [PMID: 11028487]
9. Chung MK, Shemanski L, Sherman DG, Greene HL, Hogan DB, Kellen JC, et al AFFIRM Investigators. Functional status in rate- versus rhythm-control strategies for atrial fibrillation: results of the Atrial Fibrillation Follow-Up Investigation of Rhythm Management (AFFIRM) Functional Status Substudy. J Am Coll Cardiol. 2005;46:1891-9. [PMID: 16286177] (Pubitemid 41579813)
10. Hagens VE, Ranchor AV, Van Sonderen E, Bosker HA, Kamp O, Tijssen JG, et al RACE Study Group. Effect of rate or rhythm control on quality of life in persistent atrial fibrillation. Results from the Rate Control Versus Electrical Cardioversion (RACE) Study. J Am Coll Cardiol. 2004;43:241-7. [PMID: 14736444] (Pubitemid 38201151)
11. Fuster V, Rydén LE, Cannom DS, Crijns HJ, Curtis AB, Ellenbogen KA, et al; American College of Cardiology. ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: full text: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 guidelines for the management of patients with atrial fibrillation) developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. Europace. 2006;8:651-745. [PMID: 16987906]
12. Al-Khatib SM, Allen Lapointe N, Chatterjee R, Crowley MJ, Dupre ME, Kong DF, et al. Treatment of Atrial Fibrillation. Comparative Effectiveness Review No. 119. (Prepared by the Duke Evidence-based Practice Center under contract no. 290-2007-10066-I.) AHRQ Publication No. 13-EHC095-EF. Rockville, MD: Agency for Healthcare Research and Quality; 2013. Accessed at www.effectivehealthcare. ahrq.gov/ehc/products/358/1559/atrial-fibrillation-report-130628.pdf on 14 April 2014.
13. McNamara RL, Bass EB, Miller MR, Segal JB, Goodman SN, Kim NL, et al. Management of New Onset Atrial Fibrillation. Evidence Report/Technology Assessment No. 12. (Prepared by the Johns Hopkins University Evidenc-ebased Practice Center under contract no. 290-97-0006.) AHRQ Publication No. 01-E026. Rockville, MD: Agency for Healthcare Research and Quality; 2001. Accessed at www.ncbi.nlm.nih.gov/books/NBK33108 on 30 October 2012.
14. McNamara RL, Bass EB, Miller MR, Segal JB, Goodman SN, Kim NL, et al. Management of new onset atrial fibrillation. Evid Rep Technol Assess (Summ). 2000:1-7. [PMID: 11471248]
15. McNamara RL, Tamariz LJ, Segal JB, Bass EB. Management of atrial fibrillation: review of the evidence for the role of pharmacologic therapy, electrical cardioversion, and echocardiography. Ann Intern Med. 2003;139:1018-33. [PMID: 14678922] (Pubitemid 37531534)
16. Agency for Healthcare Research and Quality. Methods Guide for Effectiveness and Comparative Effectiveness Reviews. Rockville, MD: Agency for Healthcare Research and Quality; 2014. Accessed at www.effectivehealthcare.ahrq. gov/index.cfm/search-for-guides-reviews-and-reports/?pageaction= displayproduct&productid=318 on 31 October 2011.
17. Brignole M, Menozzi C, Gasparini M, Bongiorni MG, Botto GL, Ometto R, et al; PAF 2 Study Investigators. An evaluation of the strategy of maintenance of sinus rhythm by antiarrhythmic drug therapy after ablation and pacing therapy in patients with paroxysmal atrial fibrillation. Eur Heart J. 2002;23:892-900. [PMID: 12042011] (Pubitemid 34717425)
18. Carlsson J, Miketic S, Windeler J, Cuneo A, Haun S, Micus S, et al STAF Investigators. Randomized trial of rate-control versus rhythm-control in persistent atrial fibrillation: the Strategies of Treatment of Atrial Fibrillation (STAF) study. J Am Coll Cardiol. 2003;41:1690-6. [PMID: 12767648] (Pubitemid 36584236)
19. Hohnloser SH, Kuck KH, Lilienthal J. Rhythm or rate control in atrial fibrillation - Pharmacological Intervention in Atrial Fibrillation (PIAF): a randomised trial. Lancet. 2000;356:1789-94. [PMID: 11117910]
20. Okçün B, Yigit Z, Arat A, Küçükoglu SM. Comparison of rate and rhythm control in patients with atrial fibrillation and nonischemic heart failure. Jpn Heart J. 2004;45:591-601. [PMID: 15353870]
21. Opolski G, Torbicki A, Kosior DA, Szulc M, Wozakowska-Kaplon B, Kolodziej P, et al Investigators of the Polish How to Treat Chronic Atrial Fibrillation Study. Rate control vs rhythm control in patients with nonvalvular persistent atrial fibrillation: the results of the Polish How to Treat Chronic Atrial Fibrillation (HOT CAFE) Study. Chest. 2004;126:476-86. [PMID: 15302734] (Pubitemid 39093433)
22. Petrac D, Radic B, Radeljic V, Hamel D, Filipovic J. Ventricular pacing vs dual chamber pacing in patients with persistent atrial fibrillation after atrioventricular node ablation: open randomized study. Croat Med J. 2005;46:922-8. [PMID: 16342345] (Pubitemid 43175546)
23. Shelton RJ, Clark AL, Goode K, Rigby AS, Houghton T, Kaye GC, et al. A randomised, controlled study of rate versus rhythm control in patients with chronic atrial fibrillation and heart failure: (CAFE-II Study). Heart. 2009;95:924-30. [PMID: 19282313]
24. Talajic M, Khairy P, Levesque S, Connolly SJ, Dorian P, Dubuc M, et al AF-CHF Investigators. Maintenance of sinus rhythm and survival in patients with heart failure and atrial fibrillation. J Am Coll Cardiol. 2010;55:1796-802. [PMID: 20413028]
25. Van Gelder IC, Hagens VE, Bosker HA, Kingma JH, Kamp O, Kingma T, et al Rate Control versus Electrical Cardioversion for Persistent Atrial Fibrillation Study Group. A comparison of rate control and rhythm control in patients with recurrent persistent atrial fibrillation. N Engl J Med. 2002;347:1834-40. [PMID: 12466507] (Pubitemid 35417774)
26. Vora A, Karnad D, Goyal V, Naik A, Gupta A, Lokhandwala Y, et al. Control of heart rate versus rhythm in rheumatic atrial fibrillation: a randomized study. J Cardiovasc Pharmacol Ther. 2004;9:65-73. [PMID: 15309242] (Pubitemid 39071591)
27. Wyse DG, Waldo AL, DiMarco JP, Domanski MJ, Rosenberg Y, Schron EB, et al Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) Investigators. A comparison of rate control and rhythm control in patients with atrial fibrillation. N Engl J Med. 2002;347:1825-33. [PMID: 12466506] (Pubitemid 35417773)
28. Yildiz A, Yigit Z, Okcun B, Baskurt M, Ortak K, Kaya A, et al. Comparison of rate and rhythm control in hypertension patients with atrial fibrillation. Circ J. 2008;72:705-8. [PMID: 18441447] (Pubitemid 351716673)
29. Suman-Horduna I, Roy D, Frasure-Smith N, Talajic M, Lespérance F, Blondeau L, et al; AF-CHF Trial Investigators. Quality of life and functional capacity in patients with atrial fibrillation and congestive heart failure. J Am Coll Cardiol. 2013;61:455-60. [PMID: 23265334]
30. Khan MN, Jaïs P, Cummings J, Di Biase L, Sanders P, Martin DO, et al; PABA-CHF Investigators. Pulmonary-vein isolation for atrial fibrillation in patients with heart failure. N Engl J Med. 2008;359:1778-85. [PMID: 18946063]
31. MacDonald MR, Connelly DT, Hawkins NM, Steedman T, Payne J, Shaw M, et al. Radiofrequency ablation for persistent atrial fibrillation in patients with advanced heart failure and severe left ventricular systolic dysfunction: a randomised controlled trial. Heart. 2011;97:740-7. [PMID: 21051458]
32. Jones DG, Haldar SK, Hussain W, Sharma R, Francis DP, Rahman-Haley SL, et al. A randomized trial to assess catheter ablation versus rate control in the management of persistent atrial fibrillation in heart failure. J Am Coll Cardiol. 2013;61:1894-903. [PMID: 23500267]
33. Ricard P, Lévy S, Boccara G, Lakhal E, Bardy G. External cardioversion of atrial fibrillation: comparison of biphasic vs monophasic waveform shocks. Europace. 2001;3:96-9. [PMID: 11333061] (Pubitemid 32303339)
34. Page RL, Kerber RE, Russell JK, Trouton T, Waktare J, Gallik D, et al; BiCard Investigators. Biphasic versus monophasic shock waveform for conversion of atrial fibrillation: the results of an international randomized, double-blind multicenter trial. J Am Coll Cardiol. 2002;39:1956-63. [PMID: 12084594] (Pubitemid 34628276)
35. Khaykin Y, Newman D, Kowalewski M, Korley V, Dorian P. Biphasic versus monophasic cardioversion in shock-resistant atrial fibrillation. J Cardiovasc Electrophysiol. 2003;14:868-72. [PMID: 12890051] (Pubitemid 37006353)
36. Mortensen K, Risius T, Schwemer TF, Aydin MA, Köster R, Klemm HU, et al. Biphasic versus monophasic shock for external cardioversion of atrial flutter: a prospective, randomized trial. Cardiology. 2008;111:57-62. [PMID: 18239394]
37. Krittayaphong R, Raungrattanaamporn O, Bhuripanyo K, Sriratanasathavorn C, Pooranawattanakul S, Punlee K, et al. A randomized clinical trial of the efficacy of radiofrequency catheter ablation and amiodarone in the treatment of symptomatic atrial fibrillation. J Med Assoc Thai. 2003;86 Suppl 1:S8-16. [PMID: 12866763]
38. Wazni OM, Marrouche NF, Martin DO, Verma A, Bhargava M, Saliba W, et al. Radiofrequency ablation vs antiarrhythmic drugs as first-line treatment of symptomatic atrial fibrillation: a randomized trial. JAMA. 2005;293:2634-40. [PMID: 15928285] (Pubitemid 40744248)
39. Oral H, Pappone C, Chugh A, Good E, Bogun F, Pelosi F Jr, et al. Circumferential pulmonary-vein ablation for chronic atrial fibrillation. N Engl J Med. 2006;354:934-41. [PMID: 16510747]
40. Pappone C, Augello G, Sala S, Gugliotta F, Vicedomini G, Gulletta S, et al. A randomized trial of circumferential pulmonary vein ablation versus antiarrhythmic drug therapy in paroxysmal atrial fibrillation: the APAF Study. J Am Coll Cardiol. 2006;48:2340-7. [PMID: 17161267] (Pubitemid 44856763)
41. Stabile G, Bertaglia E, Senatore G, De Simone A, Zoppo F, Donnici G, et al. Catheter ablation treatment in patients with drug-refractory atrial fibrillation: a prospective, multi-centre, randomized, controlled study (Catheter Ablation For The Cure Of Atrial Fibrillation Study). Eur Heart J. 2006;27:216-21. [PMID: 16214831] (Pubitemid 43069040)
42. Jaïs P, Cauchemez B, Macle L, Daoud E, Khairy P, Subbiah R, et al. Catheter ablation versus antiarrhythmic drugs for atrial fibrillation: the A4 study. Circulation. 2008;118:2498-505. [PMID: 19029470]
43. Forleo GB, Mantica M, De Luca L, Leo R, Santini L, Panigada S, et al. Catheter ablation of atrial fibrillation in patients with diabetes mellitus type 2: results from a randomized study comparing pulmonary vein isolation versus antiarrhythmic drug therapy. J Cardiovasc Electrophysiol. 2009;20:22-8. [PMID: 18775050]
44. Wilber DJ, Pappone C, Neuzil P, De Paola A, Marchlinski F, Natale A, et al; ThermoCool AF Trial Investigators. Comparison of antiarrhythmic drug therapy and radiofrequency catheter ablation in patients with paroxysmal atrial fibrillation: a randomized controlled trial. JAMA. 2010;303:333-40. [PMID: 20103757]
45. Mont L, Bisbal F, Hernández-Madrid A, Pérez-Castellano N, Viñolas X, Arenal A, et al; SARA investigators. Catheter ablation vs. antiarrhythmic drug treatment of persistent atrial fibrillation: a multicentre, randomized, controlled trial (SARA study). Eur Heart J. 2014;35:501-7. [PMID: 24135832]
46. Budera P, Straka Z, Osmancík P, Vanek T, Jelínek Š, Hlavicka J, et al. Comparison of cardiac surgery with left atrial surgical ablation vs. cardiac surgery without atrial ablation in patients with coronary and/or valvular heart disease plus atrial fibrillation: final results of the PRAGUE-12 randomized multicentre study. Eur Heart J. 2012;33:2644-52. [PMID: 22930458]
47. Delle Karth G, Geppert A, Neunteufl T, Priglinger U, Haumer M, Gschwandtner M, et al. Amiodarone versus diltiazem for rate control in critically ill patients with atrial tachyarrhythmias. Crit Care Med. 2001;29:1149-53. [PMID: 11395591] (Pubitemid 32554326)
48. Demircan C, Cikriklar HI, Engindeniz Z, Cebicci H, Atar N, Guler V, et al. Comparison of the effectiveness of intravenous diltiazem and metoprolol in the management of rapid ventricular rate in atrial fibrillation. Emerg Med J. 2005;22:411-4. [PMID: 15911947] (Pubitemid 40778991)
49. Hofmann R, Steinwender C, Kammler J, Kypta A, Leisch F. Effects of a high dose intravenous bolus amiodarone in patients with atrial fibrillation and a rapid ventricular rate. Int J Cardiol. 2006;110:27-32. [PMID: 16046015] (Pubitemid 44251060)
50. Khand AU, Rankin AC, Martin W, Taylor J, Gemmell I, Cleland JG. Carvedilol alone or in combination with digoxin for the management of atrial fibrillation in patients with heart failure? J Am Coll Cardiol. 2003;42:1944-51. [PMID: 14662257] (Pubitemid 37485570)
51. Kochiadakis GE, Kanoupakis EM, Kalebubas MD, Igoumenidis NE, Vardakis KE, Mavrakis HE, et al. Sotalol vs metoprolol for ventricular rate control in patients with chronic atrial fibrillation who have undergone digitalization: a single-blinded crossover study. Europace. 2001;3:73-9. [PMID: 11271956] (Pubitemid 32192817)
52. Siu CW, Lau CP, Lee WL, Lam KF, Tse HF. Intravenous diltiazem is superior to intravenous amiodarone or digoxin for achieving ventricular rate control in patients with acute uncomplicated atrial fibrillation. Crit Care Med. 2009;37:2174-9. [PMID: 19487941]
53. Capucci A, Villani GQ, Aschieri D, Rosi A, Piepoli MF. Oral amiodarone increases the efficacy of direct-current cardioversion in restoration of sinus rhythm in patients with chronic atrial fibrillation. Eur Heart J. 2000;21:66-73. [PMID: 10610746] (Pubitemid 30042671)
54. Hemels ME, Van Noord T, Crijns HJ, Van Veldhuisen DJ, Veeger NJ, Bosker HA, et al. Verapamil versus digoxin and acute versus routine serial cardioversion for the improvement of rhythm control for persistent atrial fibrillation. J Am Coll Cardiol. 2006;48:1001-9. [PMID: 16949494] (Pubitemid 44382682)
55. Holming K. The effect of digitalis or a beta-blocker, alone or in combination, on atrial fibrillation at rest and during exercise. Ups J Med Sci. 2001;106:77-8. [PMID: 11817566]
56. Lindholm CJ, Fredholm O, Möller SJ, Edvardsson N, Kronvall T, Pettersson T, et al. Sinus rhythm maintenance following DC cardioversion of atrial fibrillation is not improved by temporary precardioversion treatment with oral verapamil. Heart. 2004;90:534-8. [PMID: 15084552]
57. Simpson CS, Ghali WA, Sanfilippo AJ, Moritz S, Abdollah H. Clinical assessment of clonidine in the treatment of new-onset rapid atrial fibrillation: a prospective, randomized clinical trial. Am Heart J. 2001;142:E3. [PMID: 11479482]
58. Thomas SP, Guy D, Wallace E, Crampton R, Kijvanit P, Eipper V, et al. Rapid loading of sotalol or amiodarone for management of recent onset symptomatic atrial fibrillation: a randomized, digoxin-controlled trial. Am Heart J. 2004;147:E3. [PMID: 14691441]
59. Tsuneda T, Yamashita T, Fukunami M, Kumagai K, Niwano S, Okumura K, et al. Rate control and quality of life in patients with permanent atrial fibrillation: the Quality of Life and Atrial Fibrillation (QOLAF) Study. Circ J. 2006;70:965-70. [PMID: 16864926] (Pubitemid 44164246)
60. Wattanasuwan N, Khan IA, Mehta NJ, Arora P, Singh N, Vasavada BC, et al. Acute ventricular rate control in atrial fibrillation: IV combination of diltiazem and digoxin vs. IV diltiazem alone. Chest. 2001;119:502-6. [PMID: 11171729] (Pubitemid 32163763)
61. Ulimoen SR, Enger S, Carlson J, Platonov PG, Pripp AH, Abdelnoor M, et al. Comparison of four single-drug regimens on ventricular rate and arrhythmia-related symptoms in patients with permanent atrial fibrillation. Am J Cardiol. 2013;111:225-30. [PMID: 23111138]
62. Ulimoen SR, Enger S, Pripp AH, Abdelnoor M, Arnesen H, Gjesdal K, et al. Calcium channel blockers improve exercise capacity and reduce N-terminal Pro-B-type natriuretic peptide levels compared with beta-blockers in patients with permanent atrial fibrillation. Eur Heart J. 2014;35:517-24. [PMID: 24135831]
63. Van Gelder IC, Groenveld HF, Crijns HJ, Tuininga YS, Tijssen JG, Alings AM, et al; RACE II Investigators. Lenient versus strict rate control in patients with atrial fibrillation. N Engl J Med. 2010;362:1363-73. [PMID: 20231232]
64. Groenveld HF, Crijns HJ, Rienstra M, Van den Berg MP, Van Veldhuisen DJ, Van Gelder IC; RACE investigators. Does intensity of rate control influence outcome in persistent atrial fibrillation? Data of the RACE study. Am Heart J. 2009;158:785-91. [PMID: 19853699]
65. Van Gelder IC, Wyse DG, Chandler ML, Cooper HA, Olshansky B, Hagens VE, et al RACE and AFFIRM Investigators. Does intensity of rate-control influence outcome in atrial fibrillation? An analysis of pooled data from the RACE and AFFIRM studies. Europace. 2006;8:935-42. [PMID: 16973686] (Pubitemid 44614202)
66. Levy T, Walker S, Mason M, Spurrell P, Rex S, Brant S, et al. Importance of rate control or rate regulation for improving exercise capacity and quality of life in patients with permanent atrial fibrillation and normal left ventricular function: a randomised controlled study. Heart. 2001;85:171-8. [PMID: 11156667] (Pubitemid 32973588)
67. Weerasooriya R, Davis M, Powell A, Szili-Torok T, Shah C, Whalley D, et al. The Australian Intervention Randomized Control of Rate in Atrial Fibrillation Trial (AIRCRAFT). J Am Coll Cardiol. 2003;41:1697-702. [PMID: 12767649] (Pubitemid 36584237)
68. Lee SH, Cheng JJ, Chen SA. A randomized, prospective comparison of anterior and posterior approaches to atrioventricular junction modification of medically refractory atrial fibrillation. Pacing Clin Electrophysiol. 2000;23:966-74. [PMID: 10879380]
69. Doshi RN, Daoud EG, Fellows C, Turk K, Duran A, Hamdan MH, et al PAVE Study Group. Left ventricular-based cardiac stimulation post AV nodal ablation evaluation (the PAVE study). J Cardiovasc Electrophysiol. 2005;16:1160-5. [PMID: 16302897]
70. Kirkutis A, Poviliunas A, Griciene P, Polena S, Yang S, Yalamanchi G, et al. Cardiac rate normalization in chronic atrial fibrillation: comparison of long-term efficacy of treatment with amiodarone versus AV node ablation and permanent His-bundle pacing. Proc West Pharmacol Soc. 2004;47:69-70. [PMID: 15633616] (Pubitemid 39564884)
71. Balla I, Petrela E, Kondili A. Pharmacological conversion of recent atrial fibrillation: a randomized, placebo-controlled study of three antiarrhythmic drugs. Anadolu Kardiyol Derg. 2011;11:600-6. [PMID: 21911317]
72. Glover BM, Walsh SJ, McCann CJ, Moore MJ, Manoharan G, Dalzell GW, et al. Biphasic energy selection for transthoracic cardioversion of atrial fibrillation. The BEST AF Trial. Heart. 2008;94:884-7. [PMID: 17591649] (Pubitemid 351914699)
73. Joglar JA, Hamdan MH, Ramaswamy K, Zagrodzky JD, Sheehan CJ, Nelson LL, et al. Initial energy for elective external cardioversion of persistent atrial fibrillation. Am J Cardiol. 2000;86:348-50. [PMID: 10922451] (Pubitemid 30462239)
74. Kawabata VS, Vianna CB, Moretti MA, Gonzalez MM, Ferreira JF, Timerman S, et al. Monophasic versus biphasic waveform shocks for atrial fibrillation cardioversion in patients with concomitant amiodarone therapy. Europace. 2007;9:143-6. [PMID: 17272337] (Pubitemid 46242031)
75. Kirchhof P, Eckardt L, Loh P, Weber K, Fischer RJ, Seidl KH, et al. Anterior-posterior versus anterior-lateral electrode positions for external cardioversion of atrial fibrillation: a randomised trial. Lancet. 2002;360:1275-9. [PMID: 12414201] (Pubitemid 35284617)
76. Kirchhof P, Mönnig G, Wasmer K, Heinecke A, Breithardt G, Eckardt L, et al. A trial of self-adhesive patch electrodes and hand-held paddle electrodes for external cardioversion of atrial fibrillation (MOBIPAPA). Eur Heart J. 2005;26:1292-7. [PMID: 15734772]
77. Korantzopoulos P, Kolettis TM, Papathanasiou A, Naka KK, Kolios P, Leontaridis I, et al. Propafenone added to ibutilide increases conversion rates of persistent atrial fibrillation. Heart. 2006;92:631-4. [PMID: 16159973]
78. Nergårdh AK, Rosenqvist M, Nordlander R, Frick M. Maintenance of sinus rhythm with metoprolol CR initiated before cardioversion and repeated cardioversion of atrial fibrillation: a randomized double-blind placebo-controlled study. Eur Heart J. 2007;28:1351-7. [PMID: 17329409]
79. Singh BN, Singh SN, Reda DJ, Tang XC, Lopez B, Harris CL, et al Sotalol Amiodarone Atrial Fibrillation Efficacy Trial (SAFE-T) Investigators. Amiodarone versus sotalol for atrial fibrillation. N Engl J Med. 2005;352:1861-72. [PMID: 15872201]
80. Vijayalakshmi K, Whittaker VJ, Sutton A, Campbell P, Wright RA, Hall JA, et al. A randomized trial of prophylactic antiarrhythmic agents (amiodarone and sotalol) in patients with atrial fibrillation for whom direct current cardioversion is planned. Am Heart J. 2006;151:863. [PMID: 16569550]
81. Alatawi F, Gurevitz O, White RD, Ammash NM, Malouf JF, Bruce CJ, et al. Prospective, randomized comparison of two biphasic waveforms for the efficacy and safety of transthoracic biphasic cardioversion of atrial fibrillation. Heart Rhythm. 2005;2:382-7. [PMID: 15851340] (Pubitemid 40443622)
82. Alp NJ, Rahman S, Bell JA, Shahi M. Randomised comparison of anterolateral versus antero-posterior paddle positions for DC cardioversion of persistent atrial fibrillation. Int J Cardiol. 2000;75:211-6. [PMID: 11077136]
83. Ambler JJ, Deakin CD. A randomized controlled trial of efficacy and ST change following use of the Welch-Allyn MRL PIC biphasic waveform versus damped sine monophasic waveform for external DC cardioversion. Resuscitation. 2006;71:146-51. [PMID: 16987583] (Pubitemid 44602308)
84. Boodhoo L, Mitchell AR, Bordoli G, Lloyd G, Patel N, Sulke N. DC cardioversion of persistent atrial fibrillation: a comparison of two protocols. Int J Cardiol. 2007;114:16-21. [PMID: 16644036] (Pubitemid 44791466)
85. Boos C, Thomas MD, Jones A, Clarke E, Wilbourne G, More RS. Higher energy monophasic DC cardioversion for persistent atrial fibrillation: is it time to start at 360 joules? Ann Noninvasive Electrocardiol. 2003;8:121-6. [PMID: 12848792] (Pubitemid 38578430)
86. Brazdzionyte J, Babarskiene RM, Stanaitiene G. Anterior-posterior versus anterior-lateral electrode position for biphasic cardioversion of atrial fibrillation. Medicina (Kaunas). 2006;42:994-8. [PMID: 17211107]
87. Fragakis N, Bikias A, Delithanasis I, Konstantinidou M, Liakopoulos N, Kozirakis M, et al. Acute beta-adrenoceptor blockade improves efficacy of ibutilide in conversion of atrial fibrillation with a rapid ventricular rate. Europace. 2009;11:70-4. [PMID: 18987127]
88. Hassan S, Slim AM, Ahmad S, Kamalakannan D, Khoury R, Kakish E, et al. Conversion of atrial fibrillation to sinus rhythm during treatment with intravenous esmolol or diltiazem: a prospective, randomized comparison. J Cardiovasc Pharmacol Ther. 2007;12:227-31. [PMID: 17875950] (Pubitemid 47305431)
89. Joseph AP, Ward MR. A prospective, randomized controlled trial comparing the efficacy and safety of sotalol, amiodarone, and digoxin for the reversion of new-onset atrial fibrillation. Ann Emerg Med. 2000;36:1-9. [PMID: 10874228] (Pubitemid 30641458)
90. Kafkas NV, Patsilinakos SP, Mertzanos GA, Papageorgiou KI, Chaveles JI, Dagadaki OK, et al. Conversion efficacy of intravenous ibutilide compared with intravenous amiodarone in patients with recent-onset atrial fibrillation and atrial flutter. Int J Cardiol. 2007;118:321-5. [PMID: 17049640] (Pubitemid 46678234)
91. Kanoupakis EM, Manios EG, Mavrakis HE, Tzerakis PG, Mouloudi HK, Vardas PE. Comparative effects of carvedilol and amiodarone on conversion and recurrence rates of persistent atrial fibrillation. Am J Cardiol. 2004;94:659-62. [PMID: 15342304] (Pubitemid 39165852)
92. Manios EG, Mavrakis HE, Kanoupakis EM, Kallergis EM, Dermitzaki DN, Kambouraki DC, et al. Effects of amiodarone and diltiazem on persistent atrial fibrillation conversion and recurrence rates: a randomized controlled study. Cardiovasc Drugs Ther. 2003;17:31-9. [PMID: 12843685] (Pubitemid 36898096)
93. Marinsek M, Larkin GL, Zohar P, Bervar M, Pekolj-Bicanic M, Mocnik FS, et al. Efficacy and impact of monophasic versus biphasic countershocks for transthoracic cardioversion of persistent atrial fibrillation. Am J Cardiol. 2003;92:988-91. [PMID: 14556881] (Pubitemid 37214818)
94. Mazzocca G, Corbucci G, Venturini E, Becuzzi L. Is pretreatment with ibutilide useful for atrial fibrillation cardioversion when combined with biphasic shock? J Cardiovasc Med (Hagerstown). 2006;7:124-8. [PMID: 16645372] (Pubitemid 44159508)
95. Rashba EJ, Bouhouch R, MacMurdy KA, Shorofsky SR, Peters RW, Gold MR. Effect of shock polarity on the efficacy of transthoracic atrial defibrillation. Am Heart J. 2002;143:541-5. [PMID: 11868063] (Pubitemid 34185187)
96. Rashba EJ, Gold MR, Crawford FA, Leman RB, Peters RW, Shorofsky SR. Efficacy of transthoracic cardioversion of atrial fibrillation using a biphasic, truncated exponential shock waveform at variable initial shock energies. Am J Cardiol. 2004;94:1572-4. [PMID: 15589022] (Pubitemid 40268468)
97. Redfearn DP, Skanes AC, Lane J, Stafford PJ. Signal-averaged P wave reflects change in atrial electrophysiological substrate afforded by verapamil following cardioversion from atrial fibrillation. Pacing Clin Electrophysiol. 2006;29:1089-95. [PMID: 17038141] (Pubitemid 44581397)
98. Scholten M, Szili-Torok T, Klootwijk P, Jordaens L. Comparison of monophasic and biphasic shocks for transthoracic cardioversion of atrial fibrillation. Heart. 2003;89:1032-4. [PMID: 12923020] (Pubitemid 37051500)
99. Siaplaouras S, Buob A, Rötter C, Böhm M, Jung J. Randomized comparison of anterolateral versus anteroposterior electrode position for biphasic external cardioversion of atrial fibrillation. Am Heart J. 2005;150:150-2. [PMID: 16084162] (Pubitemid 41097443)
100. Siaplaouras S, Buob A, Rötter C, Böhm M, Jung J. Impact of biphasic electrical cardioversion of atrial fibrillation on early recurrent atrial fibrillation and shock efficacy. J Cardiovasc Electrophysiol. 2004;15:895-7. [PMID: 15333081] (Pubitemid 39180247)
101. Villani GQ, Piepoli MF, Terracciano C, Capucci A. Effects of diltiazem pretreatment on direct-current cardioversion in patients with persistent atrial fibrillation: a single-blind, randomized, controlled study. Am Heart J. 2000;140:e12. [PMID: 10966543]
102. Chen WS, Gao BR, Chen WQ, Li ZZ, Xu ZY, Zhang YH, et al. Comparison of pharmacological and electrical cardioversion in permanent atrial fibrillation after prosthetic cardiac valve replacement: a prospective randomized trial. J Int Med Res. 2013;41:1067-73. [PMID: 23794519]
103. Deakin CD, Connelly S, Wharton R, Yuen HM. A comparison of rectilinear and truncated exponential biphasic waveforms in elective cardioversion of atrial fibrillation: a prospective randomized controlled trial. Resuscitation. 2013;84:286-91. [PMID: 22842285]
104. De Simone A, Turco P, De Matteis C, La Rocca V, Nocerino P, Greco L, et al. Effect of verapamil on secondary cardioversion in patients with early atrial fibrillation recurrence after electrical cardioversion. Am J Cardiol. 2002;90:185-7. [PMID: 12106857] (Pubitemid 34775135)
105. Van Noord T, Van Gelder IC, Tieleman RG, Bosker HA, Tuinenburg AE, Volkers C, et al. VERDICT: the Verapamil versus Digoxin Cardioversion Trial: a randomized study on the role of calcium lowering for maintenance of sinus rhythm after cardioversion of persistent atrial fibrillation. J Cardiovasc Electrophysiol. 2001;12:766-9. [PMID: 11469424] (Pubitemid 32607255)
106. Bittner A, Mönnig G, Zellerhoff S, Pott C, Köbe J, Dechering D, et al. Randomized study comparing duty-cycled bipolar and unipolar radiofrequency with point-by-point ablation in pulmonary vein isolation. Heart Rhythm. 2011;8:1383-90. [PMID: 21457793]
107. Blomström-Lundqvist C, Johansson B, Berglin E, Nilsson L, Jensen SM, Thelin S, et al. A randomized double-blind study of epicardial left atrial cryoablation for permanent atrial fibrillation in patients undergoing mitral valve surgery: the SWEDish Multicentre Atrial Fibrillation study (SWEDMAF). Eur Heart J. 2007;28:2902-8. [PMID: 17984136]
108. Boersma LV, Castella M, van Boven W, Berruezo A, Yilmaz A, Nadal M, et al. Atrial fibrillation catheter ablation versus surgical ablation treatment
109. Bulava A, Haniš J, Sitek D, Ošmera O, Karpianus D, Snorek M, et al. Catheter ablation for paroxysmal atrial fibrillation: a randomized comparison between multielectrode catheter and point-by-point ablation. Pacing Clin Electrophysiol. 2010;33:1039-46. [PMID: 20528997]
110. Calò L, Lamberti F, Loricchio ML, De Ruvo E, Colivicchi F, Bianconi L, et al. Left atrial ablation versus biatrial ablation for persistent and permanent atrial fibrillation: a prospective and randomized study. J Am Coll Cardiol. 2006;47:2504-12. [PMID: 16781381]
111. Chevalier P, Leizorovicz A, Maureira P, Carteaux JP, Corbineau H, Caus T, et al. Left atrial radiofrequency ablation during mitral valve surgery: a prospective randomized multicentre study (SAFIR). Arch Cardiovasc Dis. 2009;102:769-75. [PMID: 19944393]
112. Deisenhofer I, Estner H, Reents T, Fichtner S, Bauer A, Wu J, et al. Does electrogram guided substrate ablation add to the success of pulmonary vein isolation in patients with paroxysmal atrial fibrillation? A prospective, randomized study. J Cardiovasc Electrophysiol. 2009;20:514-21. [PMID: 19207759]
113. Deneke T, Khargi K, Grewe PH, Laczkovics A, von Dryander S, Lawo T, et al. Efficacy of an additional MAZE procedure using cooled-tip radiofrequency ablation in patients with chronic atrial fibrillation and mitral valve disease. A randomized, prospective trial. Eur Heart J. 2002;23:558-66. [PMID: 11922646] (Pubitemid 35192203)
114. Di Biase L, Elayi CS, Fahmy TS, Martin DO, Ching CK, Barrett C, et al. Atrial fibrillation ablation strategies for paroxysmal patients: randomized comparison between different techniques. Circ Arrhythm Electrophysiol. 2009;2:113-9. [PMID: 19808455]
115. Dixit S, Marchlinski FE, Lin D, Callans DJ, Bala R, Riley MP, et al. Randomized ablation strategies for the treatment of persistent atrial fibrillation: RASTA study. Circ Arrhythm Electrophysiol. 2012;5:287-94. [PMID: 22139886]
116. Dixit S, Gerstenfeld EP, Callans DJ, Cooper JM, Lin D, Russo AM, et al. Comparison of cool tip versus 8-mm tip catheter in achieving electrical isolation of pulmonary veins for long-term control of atrial fibrillation: a prospective randomized pilot study. J Cardiovasc Electrophysiol. 2006;17:1074-9. [PMID: 16879626] (Pubitemid 44401566)
117. Dixit S, Gerstenfeld EP, Ratcliffe SJ, Cooper JM, Russo AM, Kimmel SE, et al. Single procedure efficacy of isolating all versus arrhythmogenic pulmonary veins on long-term control of atrial fibrillation: a prospective randomized study. Heart Rhythm. 2008;5:174-81. [PMID: 18242535] (Pubitemid 351168544)
118. Doukas G, Samani NJ, Alexiou C, Oc M, Chin DT, Stafford PG, et al. Left atrial radiofrequency ablation during mitral valve surgery for continuous atrial fibrillation: a randomized controlled trial. JAMA. 2005;294:2323-9. [PMID: 16278360] (Pubitemid 41607408)
119. Elayi CS, Verma A, Di Biase L, Ching CK, Patel D, Barrett C, et al. Ablation for longstanding permanent atrial fibrillation: results from a randomized study comparing three different strategies. Heart Rhythm. 2008;5:1658-64. [PMID: 19084800]
120. Fiala M, Chovancík J, Nevralová R, Neuwirth R, Jiravský O, Nykl I, et al. Pulmonary vein isolation using segmental versus electroanatomical circumferential ablation for paroxysmal atrial fibrillation: over 3-year results of a prospective randomized study. J Interv Card Electrophysiol. 2008;22:13-21. [PMID: 18418704]
121. Khaykin Y, Skanes A, Champagne J, Themistoclakis S, Gula L, Rossillo A, et al. A randomized controlled trial of the efficacy and safety of electroanatomic circumferential pulmonary vein ablation supplemented by ablation of complex fractionated atrial electrograms versus potential-guided pulmonary vein antrum isolation guided by intracardiac ultrasound. Circ Arrhythm Electrophysiol. 2009;2:481-7. [PMID: 19843915]
122. Pontoppidan J, Nielsen JC, Poulsen SH, Jensen HK, Walfridsson H, Pedersen AK, et al. Prophylactic cavotricuspid isthmus block during atrial fibrillation ablation in patients without atrial flutter: a randomised controlled trial. Heart. 2009;95:994-9. [PMID: 19261602]
123. Roux JF, Zado E, Callans DJ, Garcia F, Lin D, Marchlinski FE, et al. Antiarrhythmics After Ablation of Atrial Fibrillation (5A Study). Circulation. 2009;120:1036-40. [PMID: 19738139]
124. Srivastava V, Kumar S, Javali S, Rajesh TR, Pai V, Khandekar J, et al. Efficacy of three different ablative procedures to treat atrial fibrillation in patients with valvular heart disease: a randomised trial. Heart Lung Circ. 2008;17:232-40. [PMID: 18242137]
125. Tamborero D, Mont L, Berruezo A, Matiello M, Benito B, Sitges M, et al. Left atrial posterior wall isolation does not improve the outcome of circumferential pulmonary vein ablation for atrial fibrillation: a prospective randomized study. Circ Arrhythm Electrophysiol. 2009;2:35-40. [PMID: 19808442]
126. Turco P, De Simone A, La Rocca V, Iuliano A, Capuano V, Astarita C, et al. Antiarrhythmic drug therapy after radiofrequency catheter ablation in patients with atrial fibrillation. Pacing Clin Electrophysiol. 2007;30 Suppl 1:S112-5. [PMID: 17302684] (Pubitemid 46121822)
127. Van Breugel HN, Nieman FH, Accord RE, Van Mastrigt GA, Nijs JF, Severens JL, et al. A prospective randomized multicenter comparison on health-related quality of life: the value of add-on arrhythmia surgery in patients with paroxysmal, permanent or persistent atrial fibrillation undergoing valvular and/or coronary bypass surgery. J Cardiovasc Electrophysiol. 2010;21:511-20. [PMID: 19925605]
128. Verma A, Mantovan R, Macle L, De Martino G, Chen J, Morillo CA, et al. Substrate and Trigger Ablation for Reduction of Atrial Fibrillation (STAR AF): a randomized, multicentre, international trial. Eur Heart J. 2010;31:1344-56. [PMID: 20215126]
129. von Oppell UO, Masani N, O'Callaghan P, Wheeler R, Dimitrakakis G, Schiffelers S. Mitral valve surgery plus concomitant atrial fibrillation ablation is superior to mitral valve surgery alone with an intensive rhythm control strategy. Eur J Cardiothorac Surg. 2009;35:641-50. [PMID: 19233678]
130. Wang J, Meng X, Li H, Cui Y, Han J, Xu C. Prospective randomized comparison of left atrial and biatrial radiofrequency ablation in the treatment of atrial fibrillation. Eur J Cardiothorac Surg. 2009;35:116-22. [PMID: 18952450]
131. Willems S, Klemm H, Rostock T, Brandstrup B, Ventura R, Steven D, et al. Substrate modification combined with pulmonary vein isolation improves outcome of catheter ablation in patients with persistent atrial fibrillation: a prospective randomized comparison. Eur Heart J. 2006;27:2871-8. [PMID: 16782716] (Pubitemid 44871470)
132. Zhao X, Zhang J, Hu J, Liao D, Zhu Y, Mei X, et al. Pulmonary antrum radial-linear ablation for paroxysmal atrial fibrillation: interim analysis of a multicenter trial. Circ Arrhythm Electrophysiol. 2013;6:310-7. [PMID: 23434517]
133. Jonsson A, Lehto M, Ahn H, Hermansson U, Linde P, Ahlsson A, et al. Microwave ablation in mitral valve surgery for atrial fibrillation (MAMA). J Atr Fibrillation. 2012;5:13-22.
134. Packer DL, Kowal RC, Wheelan KR, Irwin JM, Champagne J, Guerra PG, et al; STOP AF Cryoablation Investigators. Cryoballoon ablation of pulmonary veins for paroxysmal atrial fibrillation: first results of the North American Arctic Front (STOP AF) pivotal trial. J Am Coll Cardiol. 2013;61:1713-23. [PMID: 23500312]
135. Fichtner S, Hessling G, Ammar S, Reents T, Estner HL, Jilek C, et al. A prospective randomized study comparing isolation of the arrhythmogenic vein versus all veins in paroxysmal atrial fibrillation. Clin Cardiol. 2013;36:422-6. [PMID: 23670880]
136. Abreu Filho CA, Lisboa LA, Dallan LA, Spina GS, Grinberg M, Scanavacca M, et al. Effectiveness of the maze procedure using cooled-tip radiofrequency ablation in patients with permanent atrial fibrillation and rheumatic mitral valve disease. Circulation. 2005;112:I20-5. [PMID: 16159816] (Pubitemid 41266648)
137. Akpinar B, Guden M, Sagbas E, Sanisoglu I, Ozbek U, Caynak B, et al. Combined radiofrequency modified maze and mitral valve procedure through a port access approach: early and mid-term results. Eur J Cardiothorac Surg. 2003;24:223-30. [PMID: 12895612] (Pubitemid 36952186)
138. Albrecht A, Kalil RA, Schuch L, Abrahão R, Sant'Anna JR, de Lima G, et al. Randomized study of surgical isolation of the pulmonary veins for correction of permanent atrial fibrillation associated with mitral valve disease. J Thorac Cardiovasc Surg. 2009;138:454-9. [PMID: 19619795]
139. Arentz T, Weber R, Bürkle G, Herrera C, Blum T, Stockinger J, et al. Small or large isolation areas around the pulmonary veins for the treatment of atrial fibrillation? Results from a prospective randomized study. Circulation. 2007;115:3057-63. [PMID: 17562956] (Pubitemid 46956494)
140. Chen M, Yang B, Chen H, Ju W, Zhang F, Tse HF, et al. Randomized comparison between pulmonary vein antral isolation versus complex fractionated electrogram ablation for paroxysmal atrial fibrillation. J Cardiovasc Electrophysiol. 2011;22:973-81. [PMID: 21539635]
141. Corrado A, Bonso A, Madalosso M, Rossillo A, Themistoclakis S, Di Biase L, et al. Impact of systematic isolation of superior vena cava in addition to pulmonary vein antrum isolation on the outcome of paroxysmal, persistent, and permanent atrial fibrillation ablation: results from a randomized study. J Cardiovasc Electrophysiol. 2010;21:1-5. [PMID: 19732237]
142. de Lima GG, Kalil RA, Leiria TL, Hatem DM, Kruse CL, Abrahão R, et al. Randomized study of surgery for patients with permanent atrial fibrillation as a result of mitral valve disease. Ann Thorac Surg. 2004;77:2089-94. [PMID: 15172273] (Pubitemid 38686593)
143. Fassini G, Riva S, Chiodelli R, Trevisi N, Berti M, Carbucicchio C, et al. Left mitral isthmus ablation associated with PV isolation: long-term results of a prospective randomized study. J Cardiovasc Electrophysiol. 2005;16:1150-6. [PMID: 16302895]
144. Gaita F, Caponi D, Scaglione M, Montefusco A, Corleto A, Di Monte F, et al. Long-term clinical results of 2 different ablation strategies in patients with paroxysmal and persistent atrial fibrillation. Circ Arrhythm Electrophysiol. 2008;1:269-75. [PMID: 19808418]
145. Gavin AR, Singleton CB, Bowyer J, McGavigan AD. Pulmonary venous isolation versus additional substrate modification as treatment for paroxysmal atrial fibrillation. J Interv Card Electrophysiol. 2012;33:101-7. [PMID: 21938518]
146. Jessurun ER, van Hemel NM, Defauw JJ, Brutel De La Rivière A, Stofmeel MA, Kelder JC, et al. A randomized study of combining maze surgery for atrial fibrillation with mitral valve surgery. J Cardiovasc Surg (Torino). 2003;44:9-18. [PMID: 12627066] (Pubitemid 36531457)
147. Katritsis DG, Ellenbogen KA, Panagiotakos DB, Giazitzoglou E, Karabinos I, Papadopoulos A, et al. Ablation of superior pulmonary veins compared to ablation of all four pulmonary veins:. J Cardiovasc Electrophysiol. 2004;15:641-5. [PMID: 15175057] (Pubitemid 38757167)
148. Kim YH, Lim HE, Pak HN, Kwak JJ, Park JS, Choi JI, et al. Role of residual potentials inside circumferential pulmonary veins ablation lines in the recurrence of paroxysmal atrial fibrillation. J Cardiovasc Electrophysiol. 2010;21:959-65. [PMID: 20367660]
149. Liu X, Tan HW, Wang XH, Shi HF, Li YZ, Li F, et al. Efficacy of catheter ablation and surgical CryoMaze procedure in patients with long-lasting persistent atrial fibrillation and rheumatic heart disease: a randomized trial. Eur Heart J. 2010;31:2633-41. [PMID: 20573636]
150. Liu X, Long D, Dong J, Hu F, Yu R, Tang R, et al. Is circumferential pulmonary vein isolation preferable to stepwise segmental pulmonary vein isolation for patients with paroxysmal atrial fibrillation? Circ J. 2006;70:1392-7. [PMID: 17062959] (Pubitemid 44679584)
151. Nilsson B, Chen X, Pehrson S, Køber L, Hilden J, Svendsen JH. Recurrence of pulmonary vein conduction and atrial fibrillation after pulmonary vein isolation for atrial fibrillation: a randomized trial of the ostial versus the extraostial ablation strategy. Am Heart J. 2006;152:537.e1-8. [PMID: 16923426]
152. Oral H, Chugh A, Good E, Igic P, Elmouchi D, Tschopp DR, et al. Randomized comparison of encircling and nonencircling left atrial ablation for chronic atrial fibrillation. Heart Rhythm. 2005;2:1165-72. [PMID: 16253904] (Pubitemid 41614159)
153. Oral H, Chugh A, Lemola K, Cheung P, Hall B, Good E, et al. Noninducibility of atrial fibrillation as an end point of left atrial circumferential ablation for paroxysmal atrial fibrillation: a randomized study. Circulation. 2004;110:2797-801. [PMID: 15505091] (Pubitemid 39473600)
154. Pires LM, Leiria TL, de Lima GG, Kruse ML, Nesralla IA, Kalil RA. Comparison of surgical cut and sew versus radiofrequency pulmonary veins isolation for chronic permanent atrial fibrillation: a randomized study. Pacing Clin Electrophysiol. 2010;33:1249-57. [PMID: 20546155]
155. Schuetz A, Schulze CJ, Sarvanakis KK, Mair H, Plazer H, Kilger E, et al. Surgical treatment of permanent atrial fibrillation using microwave energy ablation: a prospective randomized clinical trial. Eur J Cardiothorac Surg. 2003;24:475-80. [PMID: 14500062] (Pubitemid 37167992)
156. Sheikh I, Krum D, Cooley R, Dhala A, Blanck Z, Bhatia A, et al. Pulmonary vein isolation and linear lesions in atrial fibrillation ablation. J Interv Card Electrophysiol. 2006;17:103-9. [PMID: 17318445] (Pubitemid 46434830)
157. Wazni O, Marrouche NF, Martin DO, Gillinov AM, Saliba W, Saad E, et al. Randomized study comparing combined pulmonary vein-left atrial junction disconnection and cavotricuspid isthmus ablation versus pulmonary vein-left atrial junction disconnection alone in patients presenting with typical atrial flutter and atrial fibrillation. Circulation. 2003;108:2479-83. [PMID: 14610012] (Pubitemid 37444409)
158. Knaut M, Kolberg S, Brose S, Jung F. Epicardial microwave ablation of permanent atrial fibrillation during a coronary bypass and/or aortic valve operation: prospective, randomised, controlled, mono-centric study. Appl Cardiopulm Pathophysiol. 2010;14:220-8.
159. Karch MR, Zrenner B, Deisenhofer I, Schreieck J, Ndrepepa G, Dong J, et al. Freedom from atrial tachyarrhythmias after catheter ablation of atrial fibrillation: a randomized comparison between 2 current ablation strategies. Circulation. 2005;111:2875-80. [PMID: 15927974] (Pubitemid 40814179)
160. Oral H, Chugh A, Yoshida K, Sarrazin JF, Kuhne M, Crawford T, et al. A randomized assessment of the incremental role of ablation of complex fractionated atrial electrograms after antral pulmonary vein isolation for long-lasting persistent atrial fibrillation. J Am Coll Cardiol. 2009;53:782-9. [PMID: 19245970]
161. Oral H, Chugh A, Good E, Crawford T, Sarrazin JF, Kuhne M, et al. Randomized evaluation of right atrial ablation after left atrial ablation of complex fractionated atrial electrograms for long-lasting persistent atrial fibrillation. Circ Arrhythm Electrophysiol. 2008;1:6-13. [PMID: 19808388]
162. Mun HS, Joung B, Shim J, Hwang HJ, Kim JY, Lee MH, et al. Does additional linear ablation after circumferential pulmonary vein isolation improve clinical outcome in patients with paroxysmal atrial fibrillation? Prospective randomised study. Heart. 2012;98:480-4. [PMID: 22285969]
163. Sawhney N, Anousheh R, Chen W, Feld GK. Circumferential pulmonary vein ablation with additional linear ablation results in an increased incidence of left atrial flutter compared with segmental pulmonary vein isolation as an initial approach to ablation of paroxysmal atrial fibrillation. Circ Arrhythm Electrophysiol. 2010;3:243-8. [PMID: 20339034]
164. Hocini M, Jaïs P, Sanders P, Takahashi Y, Rotter M, Rostock T, et al. Techniques, evaluation, and consequences of linear block at the left atrial roof in paroxysmal atrial fibrillation: a prospective randomized study. Circulation. 2005;112:3688-96. [PMID: 16344401]
165. Haïssaguerre M, Sanders P, Hocini M, Hsu LF, Shah DC, Scavée C, et al. Changes in atrial fibrillation cycle length and inducibility during catheter ablation and their relation to outcome. Circulation. 2004;109:3007-13. [PMID: 15184286]
166. Wang XH, Liu X, Sun YM, Shi HF, Zhou L, Gu JN. Pulmonary vein isolation combined with superior vena cava isolation for atrial fibrillation ablation: a prospective randomized study. Europace. 2008;10:600-5. [PMID: 18442966] (Pubitemid 351775300)
167. Wang YL, Liu X, Tan HW, Zhou L, Jiang WF, Gu J, et al. Evaluation of linear lesions in the left and right atrium in ablation of long-standing atrial fibrillation. Pacing Clin Electrophysiol. 2013;36:1202-10. [PMID: 23678857]
168. Bogun F, Bender B, Li YG, Hohnloser SH. Ablation of atypical atrial flutter guided by the use of concealed entrainment in patients without prior cardiac surgery. J Cardiovasc Electrophysiol. 2000;11:136-45. [PMID: 10709707] (Pubitemid 30106547)
169. Katritsis DG, Panagiotakos DB, Karvouni E, Giazitzoglou E, Korovesis S, Paxinos G, et al. Comparison of effectiveness of carvedilol versus bisoprolol for maintenance of sinus rhythm after cardioversion of persistent atrial fibrillation. Am J Cardiol. 2003;92:1116-9. [PMID: 14583369] (Pubitemid 37329541)
170. Le Heuzey JY, De Ferrari GM, Radzik D, Santini M, Zhu J, Davy JM. A short-term, randomized, double-blind, parallel-group study to evaluate the efficacy and safety of dronedarone versus amiodarone in patients with persistent atrial fibrillation: the DIONYSOS study. J Cardiovasc Electrophysiol. 2010;21:597-605. [PMID: 20384650]
171. Roy D, Talajic M, Dorian P, Connolly S, Eisenberg MJ, Green M, et al. Amiodarone to prevent recurrence of atrial fibrillation. Canadian Trial of Atrial Fibrillation Investigators. N Engl J Med. 2000;342:913-20. [PMID: 10738049] (Pubitemid 30177051)
172. AFFIRM First Antiarrhythmic Drug Substudy Investigators. Maintenance of sinus rhythm in patients with atrial fibrillation: an AFFIRM substudy of the first antiarrhythmic drug. J Am Coll Cardiol. 2003;42:20-9. [PMID: 12849654]
173. Bellandi F, Simonetti I, Leoncini M, Frascarelli F, Giovannini T, Maioli M, et al. Long-term efficacy and safety of propafenone and sotalol for the maintenance of sinus rhythm after conversion of recurrent symptomatic atrial fibrillation. Am J Cardiol. 2001;88:640-5. [PMID: 11564387] (Pubitemid 32831097)
174. De Simone A, De Pasquale M, De Matteis C, Canciello M, Manzo M, Sabino L, et al. VErapamil plus antiarrhythmic drugs reduce atrial fibrillation recurrences after an electrical cardioversion (VEPARAF Study). Eur Heart J. 2003;24:1425-9. [PMID: 12909071] (Pubitemid 36961832)
175. Kochiadakis GE, Igoumenidis NE, Hamilos ME, Tzerakis PG, Klapsinos NC, Chlouverakis GI, et al. Sotalol versus propafenone for long-term maintenance of normal sinus rhythm in patients with recurrent symptomatic atrial fibrillation. Am J Cardiol. 2004;94:1563-6. [PMID: 15589019] (Pubitemid 40268465)
176. Kochiadakis GE, Igoumenidis NE, Hamilos MI, Tzerakis PG, Klapsinos NC, Zacharis EA, et al. Long-term maintenance of normal sinus rhythm in patients with current symptomatic atrial fibrillation: amiodarone vs propafenone, both in low doses. Chest. 2004;125:377-83. [PMID: 14769712] (Pubitemid 38223611)
177. Kochiadakis GE, Igoumenidis NE, Marketou ME, Kaleboubas MD, Simantirakis EN, Vardas PE. Low dose amiodarone and sotalol in the treatment of recurrent, symptomatic atrial fibrillation: a comparative, placebo controlled study. Heart. 2000;84:251-7. [PMID: 10956284]
178. Kochiadakis GE, Marketou ME, Igoumenidis NE, Chrysostomakis SI, Mavrakis HE, Kaleboubas MD, et al. Amiodarone, sotalol, or propafenone in atrial fibrillation: which is preferred to maintain normal sinus rhythm? Pacing Clin Electrophysiol. 2000;23:1883-7. [PMID: 11139949]
179. Plewan A, Lehmann G, Ndrepepa G, Schreieck J, Alt EU, Schömig A, et al. Maintenance of sinus rhythm after electrical cardioversion of persistent atrial fibrillation; sotalol vs bisoprolol. Eur Heart J. 2001;22:1504-10. [PMID: 11482924] (Pubitemid 32769178)
180. Bertaglia E, D'Este D, Zerbo F, Zoppo F, Delise P, Pascotto P. Success of serial external electrical cardioversion of persistent atrial fibrillation in maintaining sinus rhythm; a randomized study. Eur Heart J. 2002;23:1522-8. [PMID: 12242072] (Pubitemid 35216719)
181. Ionescu-Ittu R, Abrahamowicz M, Jackevicius CA, Essebag V, Eisenberg MJ, Wynant W, et al. Comparative effectiveness of rhythm control vs rate control drug treatment effect on mortality in patients with atrial fibrillation. Arch Intern Med. 2012;172:997-1004. [PMID: 22664954]
182. Cosedis Nielsen J, Johannessen A, Raatikainen P, Hindricks G, Walfridsson H, Kongstad O, et al. Radiofrequency ablation as initial therapy in paroxysmal atrial fibrillation. N Engl J Med. 2012;367:1587-95. [PMID: 23094720]